Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Papaverine for Renal Artery Blood Flow in Robot-assisted Partial Nephrectomy
NCT04162834Phase 4Completed
- Sponsor
- Asan Medical Center
- Start
- Nov 2019
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of papaverine in kidney cancer (2 arms), sponsored by Asan Medical Center. Primary endpoint: Renal artery blood flow. Started Nov 2019; status: completed.
02
Drugs
papaverine
03
Conditions
kidney cancer
Beyond the preview
Go deeper on NCT04162834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04162834.